| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.16 | 8e-05 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | erlotinib:PLX-4032 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0005 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.001 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.11 | 0.003 |
| mRNA | necrostatin-1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.16 | 0.005 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.007 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.008 |